Nobelpharma Co., Ltd. of Tokyo at MEDICA 2017 in Düsseldorf -- MEDICA Trade Fair
Manufacturers

Nobelpharma Co., Ltd.

Kyodo Building, 12-10, Nihonbashi-Kobunacho, Chuo-ku, 103-0024 Tokyo
Japan

Telephone +81 3 56511152
Fax +81 3 56511222
info@nobelpharma.co.jp

This company is co-exhibitor of
Foundation for Biomedical Research and Innovation

Hall map

MEDICA 2017 hall map (Hall 16): stand B51

Fairground map

MEDICA 2017 fairground map: Hall 16

Contact

Yoshiki Kida

Director
Global Business Group

12-10 Nihonbashi-kobunacho, Chuo-ku
103-0024 Tokyo, Japan

Phone
+81-3-5651-1152

Fax
+81-3-5651-1222

Email
kida@nobelpharma.co.jp

Our range of products

Product categories

  • 01  Electromedical equipment / Medical Technology
  • 01.03  Therapie and physical medicine
  • 01.03.03  Implants and protheses

Implants and protheses

Company news

Date

Topic

Download

Jul 7, 2017

Marketing Approval Application Submitted to MHLW for NPC-17 (titanium bridge)

Nobelpharma Co., Ltd. (Chuo-ku, Tokyo) has submitted its application for marketing approval for NPC-17 (titanium bridge) to the Ministry of Health, Labour and Welfare on June 30.
NPC-17 (hereafter “this product”) is used for type II thyroplasty for the treatment of adductor spasmodic dysphonia. Type II thyroplasty using this product is a medical technique unique to Japan that was developed in 2001 ahead of the rest of the world by Dr. Nobuhiko Isshiki, Professor Emeritus, Kyoto University, as a definitive treatment for the symptoms of adductor spasmodic dysphonia.
This product was the first medical device to receive the SAKIGAKE designation from the Ministry of
Health, Labour and Welfare in February of last year, upon fulfilling the criteria for innovativeness, the
importance of the target disease, extremely high efficacy for the target disease, and the intent for early
development and application in Japan ahead of the rest of the world.

More Less

About us

Company details

We, Nobelpharma, born in 2003 to fulfill the mission of "Contribute to medical care by developing, manufacturing and delivering essential medicines that other company do not pursue," have obtained approvals for the manufacture and sales of new drugs in numbers on par with large pharmaceutical companies in a little more than 10 years, and we have been providing these drugs to patients. We take much pride in the corporate philosophy that is unique to Nobelpharma that made this possible.

More Less

Company data

Sales volume

50-99 Mio US $

Number of employees

100-499

Area of business

Electromedical equipment / Medical Technology

Company information as a PDF file